Timber pharmaceuticals provides business update and announces first quarter 2021 financial results

Basking ridge, nj, may 11, 2021 (globe newswire) -- via newmediawire -- timber pharmaceuticals, inc. ("timber" or the “company”) (nyse american: tmbr), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the first quarter ended march 31, 2021.
TMBR Ratings Summary
TMBR Quant Ranking